Share this
a startup makes it easy for labs to get remote microsamples
by Guest Contributor on Mar 1, 2021 9:00:00 AM
Interestingsamples, a young and ambitious startup in Slovakia, is making it easy for labs and researchers in Europe to get bio-fluid specimen microsamples for a range of research studies.
Every research study or clinical study is plagued by challenges. These can include a drawn-out approval process, difficulty with recruiting enough participants, and problems with gathering specimen samples for analysis and data collection.
A Solution for Researchers and Study Participants
Interestingsamples aims to make things easier with a platform they have developed to overcome such challenges, and to handle many of the mundane tasks that researchers typically have to manage when organizing a study in their lab. The services provided by Interestingsamples are intended to free up researchers to spend more time focusing on other things, such as method development, data analysis, and publishing articles about their work in peer-reviewed journals.
Simultaneously, Interestingsamples wants to make participation in research studies a cool and attractive activity for study participants. The company does this with a playful approach to messaging on their website, and by introducing social media functionality and gamification (still in development).
On their website, Interestingsamples engages potential study volunteers with fun artwork and messages that encourage their participation to help accelerate scientific research from the comfort of their living-room couch. "Everything can be done from a couch in your living room," reads a call-to-action on one recruitment page. "Be a pioneer of couch-based studies."
Currently, Interestingsamples is focusing solely on supporting studies that use microsamples of blood, though future studies they support may include microsamples of other bio-fluids, such as urine or saliva.
The Interestingsamples team predicts that remote blood microsampling will become the remote monitoring method of choice in the near future.
Microsamples Support a Timely Pilot Study
Interestingsamples is currently finishing up its first pilot study, which focuses on screening samples for new psychoactive substances. The study is being conducted by the Forensics Medicine Department of the Medical University Innsbruck in Austria, led by Associate Professor Herbert Oberacher. For this study, Interestingsamples was tasked with getting approvals, recruiting study volunteers, and coordinating remote blood microsample collection from 50 recreational users of new psychoactive drugs.
A major concern about the new psychoactive drugs on the market is that they are produced from crude chemicals using uncontrolled methods, and thus, pose significant health risks, especially to young people. A goal of this European study is to ascertain if either volumetric absorptive microsampling (VAMS®) of capillary blood using Mitra® devices or dried blood spot (DBS) sampling on filter paper cards are viable ways to monitor these new drugs in the population.
Study Organization & Coordination Simplified
Interestingsamples achieves its goal of simplifying the study organization process with a highly automated online platform that is designed to minimize human involvement in the study. The platform provides all necessary information to the potential study participant, and guides the participant throughout the study. This guidance includes access to instructional videos and other materials that explain how to correctly self-collect a microsample using the Mitra® device or a DBS card.
Either or both of these sample collection tools are provided to participants in a customizable kit sent to them from Interestingsamples. The kits are designed for shipment of the sample collection materials and the specimen samples via regular mail. This convenient system enables real-world applications of remote blood collection for virtual research studies. Interestingsamples also handles pseudonymization, or secure coding, of sensitive medical data associated with study participants and microsamples.
Encouraged by the positive feedback from the pilot study, the young startup is currently looking for first adopters of its platform and services. They are seeking researchers working in the areas of biomarker search, analytical method development or early disease diagnostics. The Interestingsamples team is happy to collaborate with smaller university research groups, private companies new to blood microsampling, or established laboratories that need blood microsamples from a defined patient pool or population group.
If you are a researcher based in Europe with a study in mind, but you don't have enough manpower to obtain all the approvals, recruit and coordinate all the study participants, and manage various other study tasks, Interestingsamples might be able to help. To learn more, contact co-founder Maros Mastrak via email at: maros.mastrak@interestingsamples.com.
Artwork credit: Interestingsamples Artist & Graphic Designer Maria Brdeckova
Image credit: Neoteryx
Share this
- Microsampling (206)
- Research, Remote Research (119)
- Venipuncture Alternative (106)
- Clinical Trials, Clinical Research (83)
- Mitra® Device (73)
- Therapeutic Drug Monitoring, TDM (50)
- Dried Blood Spot, DBS (38)
- Biomonitoring, Health, Wellness (31)
- Infectious Disease, Vaccines, COVID-19 (24)
- Decentralized Clinical Trial (DCT) (22)
- Blood Microsampling, Serology (21)
- Omics, Multi-Omics (19)
- Specimen Collection (17)
- Toxicology, Doping, Drug/Alcohol Monitoring, PEth (17)
- hemaPEN® Device (13)
- Preclinical Research, Animal Studies (12)
- Skin Microsampling, Microbiopsy (12)
- Pharmaceuticals, Drug Development (9)
- Harpera Device (5)
- Industry News, Microsampling News (5)
- Antibodies, MAbs (3)
- Company Press Release, Product Press Release (3)
- Environmental Toxins, Exposures (1)
- November 2024 (1)
- October 2024 (3)
- September 2024 (1)
- June 2024 (1)
- May 2024 (1)
- April 2024 (4)
- March 2024 (1)
- February 2024 (2)
- January 2024 (4)
- December 2023 (3)
- November 2023 (3)
- October 2023 (3)
- September 2023 (3)
- July 2023 (3)
- June 2023 (2)
- April 2023 (2)
- March 2023 (2)
- February 2023 (2)
- January 2023 (3)
- December 2022 (2)
- November 2022 (3)
- October 2022 (4)
- September 2022 (3)
- August 2022 (5)
- July 2022 (2)
- June 2022 (2)
- May 2022 (4)
- April 2022 (3)
- March 2022 (3)
- February 2022 (4)
- January 2022 (5)
- December 2021 (3)
- November 2021 (5)
- October 2021 (3)
- September 2021 (3)
- August 2021 (4)
- July 2021 (4)
- June 2021 (4)
- May 2021 (4)
- April 2021 (3)
- March 2021 (5)
- February 2021 (4)
- January 2021 (4)
- December 2020 (3)
- November 2020 (5)
- October 2020 (4)
- September 2020 (3)
- August 2020 (3)
- July 2020 (6)
- June 2020 (4)
- May 2020 (4)
- April 2020 (3)
- March 2020 (6)
- February 2020 (3)
- January 2020 (4)
- December 2019 (5)
- November 2019 (4)
- October 2019 (2)
- September 2019 (4)
- August 2019 (4)
- July 2019 (3)
- June 2019 (7)
- May 2019 (6)
- April 2019 (5)
- March 2019 (6)
- February 2019 (5)
- January 2019 (8)
- December 2018 (3)
- November 2018 (4)
- October 2018 (7)
- September 2018 (6)
- August 2018 (5)
- July 2018 (8)
- June 2018 (6)
- May 2018 (5)
- April 2018 (6)
- March 2018 (4)
- February 2018 (6)
- January 2018 (4)
- December 2017 (2)
- November 2017 (3)
- October 2017 (2)
- September 2017 (4)
- August 2017 (2)
- July 2017 (4)
- June 2017 (5)
- May 2017 (6)
- April 2017 (6)
- March 2017 (5)
- February 2017 (4)
- January 2017 (1)
- July 2016 (3)
- May 2016 (1)
- April 2016 (2)
No Comments Yet
Let us know what you think